Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02065102
Other study ID # 12/R/CAR/13
Secondary ID
Status Completed
Phase N/A
First received February 12, 2014
Last updated March 5, 2014
Start date November 2012
Est. completion date March 2014

Study information

Verified date March 2014
Source Royal Infirmary of Edinburgh
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Observational

Clinical Trial Summary

Coronary artery stenting has evolved as an effective treatment for angina and involves stretching up narrowings within the heart arteries using a balloon (coronary angioplasty) before implanting a small metal scaffold (stent) to splint the artery open. It is imperative that stents are fully expanded when they are deployed. If not, then patients are exposed to the serious risk of a blood clot forming in the stent (stent thrombosis), or the stent renarrowing (restenosis). One fifth of patients experiencing stent thrombosis will die and 70% will suffer a heart attack. Restenosis is associated with recurrent angina and heart attacks.

Arguably, visualising stents and ensuring adequate stent expansion is most challenging in patients with extensive hardening, or calcification, of the heart arteries. Optical coherence tomography is a novel technique that utilises near-infrared light to look inside small blood vessels in fine detail. It is 10 times more powerful than the best existing technique, intravascular ultrasound.

The purpose of this study is to compare the utility of optical coherence tomography with intravascular ultrasound in patients with heavily calcified heart arteries undergoing rotational atherectomy and coronary stent insertion. It is hoped that the results of this pilot study will provide proof-of-principle and justification for a larger clinical trial to formally assess the role of optical coherence tomography to guide coronary angioplasty and stenting in patients with heavily calcified coronary arteries.


Description:

Twelve patients undergoing rotational atherectomy and coronary stenting for angina in Lothian will be recruited. Rotational atherectomy and stent implantation will be performed as part of routine clinical care. Immediately following stent implantation paired intravascular images of the implanted stent will be obtained using both intravascular ultrasound and optical coherence tomography. The stent will then be further dilated at high pressure with a non compliant balloon and the intravascular images repeated with both intravascular ultrasound and optical coherence tomography. The images obtained will be available to the operator to guide further treatment.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date March 2014
Est. primary completion date March 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing percutaneous coronary intervention requiring rotational atherectomy and coronary stent implantation for calcified coronary artery disease.

- Ability to give informed consent.

Exclusion Criteria:

- Inability to provide informed consent.

- Acute myocardial infarction.

- Cardiogenic shock.

- Renal failure (eGFR <30 mL/min) in patients who are not on dialysis.

- Pregnancy.

- Contrast allergy.

Study Design

Observational Model: Case-Crossover, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom Royal Infirmary of Edinburgh Edinburgh Lothian

Sponsors (1)

Lead Sponsor Collaborator
Royal Infirmary of Edinburgh

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stent malposition expressed as % of total stent area The amount of stent not in direct contact with the blood vessel wall (malposition) expressed as a % of total stent area. Day 1 No
See also
  Status Clinical Trial Phase
Completed NCT04097912 - Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Withdrawn NCT03134105 - A Wearable EducAtional Intervention to REduce Angina N/A
Completed NCT02832115 - Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention Phase 4
Completed NCT02265796 - Ranolazine Among Unrevascularized Chronic Stable Angina Patients Phase 2
Terminated NCT00221182 - Stem Cell Study for Patients With Heart Disease Phase 1/Phase 2
Completed NCT01721096 - XIENCE PRIME Japan Post-Marketing Surveillance (PMS)
Recruiting NCT01214499 - Prospective, Controlled and Randomized Clinical Trial on Cardiac Cell Regeneration With Laser and Autologous Bone Marrow Stem Cells, in Patients With Coronary Disease and Refractory Angina Phase 2
Terminated NCT01285297 - Safety Study of Transmyocardial Revascularization (TMR) With Bone Marrow Aspirate (BMAC) for Angina Reduction N/A
Withdrawn NCT00774891 - Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography N/A
Completed NCT02707783 - Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina
Completed NCT00946725 - To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg Phase 1
Recruiting NCT02439541 - Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Phase 1/Phase 2
Completed NCT02341664 - Patient and Provider Assessment of Lipid Management Registry
Withdrawn NCT00657514 - Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease Phase 4
Recruiting NCT01361659 - Shockwave Treatment for Advanced Angina in Maastricht N/A
Recruiting NCT05786417 - LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions Phase 4
Withdrawn NCT02507050 - Ivabradine and Post-revascularisation Microcirculatory Dysfunction Phase 4
Active, not recruiting NCT02468960 - Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS) N/A
Completed NCT01086228 - XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan N/A
Completed NCT00824005 - Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study) Phase 2